Katherine Falloon, Zahra Dossaji, Pooja Mude, Suha Abushamma, Ashwin Ananthakrishnan, Edward L Barnes, Jaideep Bhalla, Abhik Bhattacharya, Shashank Cheemalavagu, Jean-Fred Colombel, Raymond K Cross, Joerg Ermann, Christina Ha, Hans Herfarth, Sara Horst, Jason Hou, M Elaine Husni, Theresa M Kline, Kristine A Kuhn, Millie D Long, Edward V Loftus, Dana J Lukin, Aditi Patel, David T Rubin, Ellen J Scherl, Samir A Shah, Bernadette C Siaton, Joseph Sleiman, Taha Qazi, Michael H Weisman, Benjamin L Cohen, Brian G Feagan, Florian Rieder
{"title":"Diagnosis of Inflammatory Bowel Disease-Associated Peripheral Arthritis: A Systematic Review.","authors":"Katherine Falloon, Zahra Dossaji, Pooja Mude, Suha Abushamma, Ashwin Ananthakrishnan, Edward L Barnes, Jaideep Bhalla, Abhik Bhattacharya, Shashank Cheemalavagu, Jean-Fred Colombel, Raymond K Cross, Joerg Ermann, Christina Ha, Hans Herfarth, Sara Horst, Jason Hou, M Elaine Husni, Theresa M Kline, Kristine A Kuhn, Millie D Long, Edward V Loftus, Dana J Lukin, Aditi Patel, David T Rubin, Ellen J Scherl, Samir A Shah, Bernadette C Siaton, Joseph Sleiman, Taha Qazi, Michael H Weisman, Benjamin L Cohen, Brian G Feagan, Florian Rieder","doi":"10.1093/ibd/izae114","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Inflammatory bowel disease (IBD)-associated peripheral spondyloarthritis (pSpA) decreases quality of life and remains poorly understood. Given the prevalence of this condition and its negative impact, it is surprising that evidence-based disease definitions and diagnostic strategies are lacking. This systematic review summarizes available data to facilitate development and validation of diagnostics, patient-reported outcomes, and imaging indices specific to this condition.</p><p><strong>Methods: </strong>A literature search was conducted. Consensus or classification criteria, case series, cross-sectional studies, cohort studies, and randomized controlled trials related to diagnosis were included.</p><p><strong>Results: </strong>A total of 44 studies reporting data on approximately 1500 patients with pSpA were eligible for analysis. Data quality across studies was only graded as fair to good. Due to large heterogeneity, meta-analysis was not possible. The majority of studies incorporated patient-reported outcomes and a physical examination. A total of 13 studies proposed or validated screening tools, consensus, classification, or consensus criteria. A total of 28 studies assessed the role of laboratory tests, none of which were considered sufficiently accurate for use in diagnosis. A total of 17 studies assessed the role of imaging, with the available literature insufficient to fully endorse any imaging modality as a robust diagnostic tool.</p><p><strong>Conclusions: </strong>This review highlights existing inconsistency and lack of a clear diagnostic approach for IBD-associated pSpA. Given the absence of an evidence-based approach, a combination of existing criteria and physician assessment should be utilized. To address this issue comprehensively, our future efforts will be directed toward pursuit of a multidisciplinary approach aimed at standardizing evaluation and diagnosis of IBD-associated pSpA.</p>","PeriodicalId":13623,"journal":{"name":"Inflammatory Bowel Diseases","volume":" ","pages":"812-842"},"PeriodicalIF":4.5000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Inflammatory Bowel Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ibd/izae114","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Inflammatory bowel disease (IBD)-associated peripheral spondyloarthritis (pSpA) decreases quality of life and remains poorly understood. Given the prevalence of this condition and its negative impact, it is surprising that evidence-based disease definitions and diagnostic strategies are lacking. This systematic review summarizes available data to facilitate development and validation of diagnostics, patient-reported outcomes, and imaging indices specific to this condition.
Methods: A literature search was conducted. Consensus or classification criteria, case series, cross-sectional studies, cohort studies, and randomized controlled trials related to diagnosis were included.
Results: A total of 44 studies reporting data on approximately 1500 patients with pSpA were eligible for analysis. Data quality across studies was only graded as fair to good. Due to large heterogeneity, meta-analysis was not possible. The majority of studies incorporated patient-reported outcomes and a physical examination. A total of 13 studies proposed or validated screening tools, consensus, classification, or consensus criteria. A total of 28 studies assessed the role of laboratory tests, none of which were considered sufficiently accurate for use in diagnosis. A total of 17 studies assessed the role of imaging, with the available literature insufficient to fully endorse any imaging modality as a robust diagnostic tool.
Conclusions: This review highlights existing inconsistency and lack of a clear diagnostic approach for IBD-associated pSpA. Given the absence of an evidence-based approach, a combination of existing criteria and physician assessment should be utilized. To address this issue comprehensively, our future efforts will be directed toward pursuit of a multidisciplinary approach aimed at standardizing evaluation and diagnosis of IBD-associated pSpA.
期刊介绍:
Inflammatory Bowel Diseases® supports the mission of the Crohn''s & Colitis Foundation by bringing the most impactful and cutting edge clinical topics and research findings related to inflammatory bowel diseases to clinicians and researchers working in IBD and related fields. The Journal is committed to publishing on innovative topics that influence the future of clinical care, treatment, and research.